Platelet Rich Plasma (PRP) Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Platelet Rich Plasma (PRP) Market By Product Type (Pure Platelet Rich Plasma, Pure Platelet Rich Fibrin, Leukocyte-Platelet Rich Fibrin, Others), By Application (General Surgery, Neurosurgery, Cardiac Surgery, Orthopedic Surgery, Others), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), Others), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

The global platelet rich plasma (PRP) market size was estimated at USD 474.1 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 12.2% from 2022 to 2028. Platelet Rich Plasma (PRP) Market is a permanent solution for various conditions such as ligament/tendon sprains, arthritis, and tears. Platelet rich plasma (PRP) therapy is usually done by utilizing the body’s natural healing process. In this therapy, the concentration of platelets are injected into the damaged tendons, joints and ligaments in order to accelerate healing that anticipates tissue repair. The platelets are considered to be rich in growth and healing factors. The Platelet rich plasma (PRP) injections are used in the treatment of various conditions such as shoulder pain and instability, lumbar spine disc pain, knee sprains and instability, hamstring and hip strains, ankle sprains, knee, hip, and other joint osteoarthritis among others. The major variables that are considerably boosting the target market’s growth are Some of the key determinants driving the platelet rich plasma market globally are an increase in the number of orthopaedic surgeries and sports injuries, an increase in the number of cosmetic surgeries, growing awareness about platelet rich plasma treatment in dental health, approval of new devices and the discovery of new application areas, rising geriatric population, and a surge in awareness among the global population. The significant volatility in the price of platelet rich plasma therapy, on the other hand, as well as inadequate reimbursement policies, would stifle the platelet rich plasma market’s growth.

Platelet Rich Plasma (PRP) Market

MARKET SUMMARY
-
12.2% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 12.2%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Platelet Rich Plasma (PRP) Market

  • The report on the global platelet-rich plasma (PRP) market gives historical, current, and future market sizes (US$ Mn) based on product type, application, end-user, and region.
  • Platelet Rich Plasma (PRP) Market report gives a comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and the Middle East, and Africa.
Key Players
  • Hoffman-La Roche Ltd. (Switzerland)
  • Abbott Laboratories (U.S)
  • Siemens Healthcare Inc. (Germany)
  • Thermo Fischer Scientific, Inc. (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S)
  • Biocept, Inc (U.S.)
Platelet Rich Plasma (PRP) Market Dynamics

Increase in the geriatric population along with increase in health issues are the key factors attributing the growth of Platelet rich plasma (PRP) market. The rising applications of platelet rich plasma (PRP) in various areas anticipated to fuel the growth of the market. The soaring use of PRP application in the cosmetic surgeries is boosting the growth of the market. The successful application of PRP in the orthopedic disorders such as Achilles tendinopathy, knee osteoarthritis, rotator cuff tears, and lateral epicondylitis has enhanced the growth of the Platelet rich plasma market. Growing incidence of sport injuries is adding scope for further growth in the market. However, the high risk of contamination owing to improper storage is hampering the growth of the market. The difficulty in quality control of test results is hindering the growth of the Platelet rich plasma market.


North-America Got Significant Share

Platelet Rich Plasma (PRP) Market

Geographically, global platelet rich plasma (PRP) market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America platelet rich plasma (PRP) market is set to expand at significant CAGR owing to increase in the number of surgeries due to rise in prevalence of cardiac and neurodegenerative disorders, advancements in healthcare technology, and presence of significant market players in the North America. Europe platelet rich plasma (PRP) market has lucrative growth attributed to increase in demand for cosmetic surgeries, increase in the number of sports injuries, and rise in focus on R&D to develop the newer products are anticipated to propel the market. However, Asia Pacific platelet rich plasma (PRP) market is poised to grow due to entry of market players into Asia Pacific countries, increase in the number of surgical procedures due to rise in medical tourism, and grow in geriatric population in India and China are surge the market.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East
Platelet Rich Plasma (PRP) Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The platelet-rich plasma market is projected to expand at a CAGR of 5.7% during the forecast period

 

Abbott Laboratories (U.S),Siemens Healthcare Inc. (Germany), Thermo Fischer Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S), Biocept, Inc (U.S.)

North America is the fastest-growing region for platelet rich plasma market

 


Report

Table Of Content


Report

Company Profile

  • Hoffman-La Roche Ltd. (Switzerland)
  • Abbott Laboratories (U.S)
  • Siemens Healthcare Inc. (Germany)
  • Thermo Fischer Scientific, Inc. (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S)
  • Biocept, Inc (U.S.)
  • Illumina, Inc., (U.S)
  • AstraZeneca plc, (U.K)
  • Epigenomics AG (Germany)
  • Quest Diagnostics Incorporated (U.S.)
  • Myriad Genetics, Inc.(U.S.

Description

The global platelet rich plasma (PRP) market size was estimated at USD 474.1 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 12.2% from 2022 to 2028. Platelet Rich Plasma (PRP) Market is a permanent solution for various conditions such as ligament/tendon sprains, arthritis, and tears. Platelet rich plasma (PRP) therapy is usually done by utilizing the body’s natural healing process. In this therapy, the concentration of platelets are injected into the damaged tendons, joints and ligaments in order to accelerate healing that anticipates tissue repair. The platelets are considered to be rich in growth and healing factors. The Platelet rich plasma (PRP) injections are used in the treatment of various conditions such as shoulder pain and instability, lumbar spine disc pain, knee sprains and instability, hamstring and hip strains, ankle sprains, knee, hip, and other joint osteoarthritis among others. The major variables that are considerably boosting the target market’s growth are Some of the key determinants driving the platelet rich plasma market globally are an increase in the number of orthopaedic surgeries and sports injuries, an increase in the number of cosmetic surgeries, growing awareness about platelet rich plasma treatment in dental health, approval of new devices and the discovery of new application areas, rising geriatric population, and a surge in awareness among the global population. The significant volatility in the price of platelet rich plasma therapy, on the other hand, as well as inadequate reimbursement policies, would stifle the platelet rich plasma market’s growth.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX